- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Anacor Pharmaceuticals Inc+ Add to Watchlist
44A:GR24.624 EUR 2.270 8.44%
As of 15:14:37 ET on 12/23/2014.
Company Profile for Anacor Pharmaceuticals Inc (44A)
Anacor Pharmaceuticals Inc. is a biopharmaceutical company developing small-molecule therapeutics derived from our boron chemistry platform. The Company is focused on developing topical applications to treat fungal, bacterial and inflammatory diseases.
Anacor Pharmaceuticals Inc
Key Executives for Anacor Pharmaceuticals Inc (44A)
|Paul L BernsPresident/CEO||Vincent P IppolitoExec VP/Chief Commercial Ofcr|
|Geoffrey M ParkerSenior VP/CFO||Kirk R MaplesSenior VP:Program Management|
|Sanjay ChandaVP/Interim Head:Drug Dev||Lee T ZaneVP:Clinical Development|